BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.3510
-0.0280 (-7.39%)
At close: May 29, 2026

BioCorRx Statistics

Total Valuation

BioCorRx has a market cap or net worth of 10.20 million. The enterprise value is 11.99 million.

Market Cap10.20M
Enterprise Value 11.99M

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026.

Earnings Date Aug 12, 2026
Ex-Dividend Date n/a

Share Statistics

BioCorRx has 29.06 million shares outstanding. The number of shares has increased by 75.23% in one year.

Current Share Class 29.06M
Shares Outstanding 29.06M
Shares Change (YoY) +75.23%
Shares Change (QoQ) +10.16%
Owned by Insiders (%) 27.82%
Owned by Institutions (%) n/a
Float 18.74M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.63
PB Ratio -0.88
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.50
EV / Sales 13.67
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.12

Current Ratio 0.12
Quick Ratio 0.08
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6.21

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -66.34%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 78.09%
Weighted Average Cost of Capital (WACC) 9.29%
Revenue Per Employee 292,295
Profits Per Employee -1.14M
Employee Count 3
Asset Turnover 0.19
Inventory Turnover 0.34

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +13.23% in the last 52 weeks. The beta is 0.17, so BioCorRx's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change +13.23%
50-Day Moving Average 0.34
200-Day Moving Average 0.36
Relative Strength Index (RSI) 48.56
Average Volume (20 Days) 3,798

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.05

Income Statement

In the last 12 months, BioCorRx had revenue of 876,884 and -3.43 million in losses. Loss per share was -0.16.

Revenue876,884
Gross Profit 829,898
Operating Income -4.84M
Pretax Income -3.52M
Net Income -3.43M
EBITDA -4.81M
EBIT -4.84M
Loss Per Share -0.16
Full Income Statement

Balance Sheet

The company has 211,911 in cash and 2.16 million in debt, with a net cash position of -1.94 million or -0.07 per share.

Cash & Cash Equivalents 211,911
Total Debt 2.16M
Net Cash -1.94M
Net Cash Per Share -0.07
Equity (Book Value) -11.62M
Book Value Per Share -0.40
Working Capital -7.51M
Full Balance Sheet

Cash Flow

Operating Cash Flow -2.04M
Capital Expenditures n/a
Depreciation & Amortization 30,355
Net Borrowing -149,702
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 94.64%
Operating Margin -552.33%
Pretax Margin -401.07%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioCorRx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -75.23%
Shareholder Yield -75.23%
Earnings Yield -33.63%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on January 22, 2019. It was a reverse split with a ratio of 0.01.

Last Split Date Jan 22, 2019
Split Type Reverse
Split Ratio 0.01

Scores

BioCorRx has an Altman Z-Score of -62.73 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -62.73
Piotroski F-Score 4